-
Mashup Score: 0Atorvastatin for Anthracycline-Associated Cardiac Dysfunction - 9 month(s) ago
This randomized trial assesses the effect of 12 months of atorvastatin vs placebo on development of cardiac dysfunction among patients with lymphoma undergoing anthracycline-based chemotherapy.
Source: jamanetwork.comCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0Inspired by an Uncle Who Was a Compassionate Family Doctor, This Nonagenarian Continues a Renowned Career in Hematology - The ASCO Post - 11 month(s) ago
Kanti R. Rai, MD Today is the era of the multidisciplinary oncology care approach, cancer staging facilitates precision in documenting disease extent, all of which improved the quality of patient care. However, in the United States, the Rai staging system is still the most commonly used clinical staging system for chronic lymphocytic…
Source: ascopost.comCategories: Hem/Oncs, Latest HeadlinesTweet-
Nice profile of Dr. Rai. Take home message: @BloodJournal will initially reject your paper even it is highlighting a novel staging system which changes the way clinicians approached the management of #CLL https://t.co/YSMtIZVKfc
-
-
Mashup Score: 2Academic Medicine Survival Guide - 11 month(s) ago
By MARTIN SAMUELS, MD The History of the Problem The European University (e.g. Italy, Germany, France, England) descended from the Church. The academic hierarchy, reflected in the regalia, has its roots in organized religion. The American University was a phenocopy of the European University, but the liberal arts college was a unique American contribution, wherein…
Source: The Health Care BlogCategories: Hem/Oncs, Latest HeadlinesTweet-
This is SO good, and so quotable. Thanks Dr. Samuels, and thanks @RogueRad for tweeting it. Academic Medicine Survival Guide https://t.co/4o47omn0IY
-
-
Mashup Score: 0Source: link.springer.comCategories: Hem/Oncs, Latest HeadlinesTweet
-
Here is the non-paywalled version - https://t.co/FtWNlHIBz1 cc: @ManniMD1 https://t.co/kOUWZNGs4k
-
-
Mashup Score: 3Necrobiotic xanthogranuloma: a 30-year single-center experience - PubMed - 12 month(s) ago
To characterize the clinical features, associated disorders, and treatment of necrobiotic xanthogranuloma (NXG), a rare non-Langerhans cell histiocytosis, we conducted a retrospective review of pathologically confirmed NXG at Mayo Clinic Arizona from 1987 to June 2017. Data on clinical findings, lab …
Source: PubMedCategories: Hem/Oncs, Latest HeadlinesTweet-
@AaronGoodman33 Just a handful https://t.co/qGsbyFFNib
-
-
Mashup Score: 1Measurable Residual Disease in Chronic Lymphocytic Leukemia: Current Understanding and Evolving Role in Clinical Practice - Current Treatment Options in Oncology - 12 month(s) ago
Treatment of chronic lymphocytic leukemia (CLL) has evolved dramatically during the last decade, from chemoimmunotherapy (CIT)-based therapies to newer B-cell receptor (BCR) signaling targeting agents, which are sometimes given as continuous schemes. Response to treatment was traditionally defined according to clinical variables designed to assign a response category. Interest in assessing for…
Source: SpringerLinkCategories: Hem/Oncs, Latest HeadlinesTweet-
MRD in #CLL: should you test? how to test? what to do with the result? Out now is our review by superstar hematology fellow Fausto Rios-Olais (@faustor) https://t.co/fZe3ojd7Y9
-
-
Mashup Score: 0Source: link.springer.comCategories: Hem/Oncs, Latest HeadlinesTweet
-
Full text access to our new review in @SpringerNature Current Oncology Reports - Allogeneic HSCT for Diffuse Large B-Cell Lymphoma: Evolving Role in the Era of CAR T-Cell Therapy #lymsm https://t.co/udolZ3IJhZ
-
-
Mashup Score: 11In the trenches - 1 year(s) ago
When I look back at the most influential clinicians who have taught me clinical reasoning and how to interact with patients, they had several traits in common. They often were enormously respected by their peers, emulated by learners, and loved by their patients. But they also seemed to have a very modest bibliography, often avoided administrative roles, and, unless their institution bestowed…
Source: The Lancet HaematologyCategories: Hem/Oncs, Latest HeadlinesTweet-
I did not expect this piece to resonate with so many people. This is dedicated to all the clinicians in the trenches. https://t.co/BfDLUH5lmq https://t.co/vKxVAnxvfv
-
-
Mashup Score: 0On dialogue and its many forms - 3 year(s) ago
I met Clarence and his family at the cancer clinic after he was diagnosed with Hodgkin lymphoma. As I explained the diagnosis, treatment strategy, and prognosis, I found myself presenting Clarence with a couple of options for therapy, detailing the pros and cons, and trying to reach a shared decision. At the end of my mini lecture, I asked Clarence what therapy he was leaning towards. Clarence…
Source: The Lancet HaematologyCategories: Hem/Oncs, Latest HeadlinesTweet-
My new essay in @TheLancetHaem on dialogue https://t.co/sNdh1e5ewD https://t.co/reqbB1tMdT
-
-
Mashup Score: 1A Record-Setting Ascent of El Capitan - 4 year(s) ago
Emily Harrington is the first woman to free-climb the Golden Gate route up El Capitan, a 3,000-foot-high monolith in Yosemite National Park, in under 24 hours.
Source: www.nytimes.comCategories: Hem/Oncs, Latest HeadlinesTweet-
Speaking of firsts 👇 https://t.co/KwHXKOslSy
-
Will you give patients with lymphoma receiving R-CHOP atorvastatin for 1 year to reduce the risk of dropping EF by at least 10% without impacting the clinical endpoint of heart failure? @JAMA_current @venkmurthy https://t.co/omGHR285oq